Key Takeaways Medicare Part D excludes drugs used solely for weight loss, but coverage may be available for medications with FDA-approved medical uses beyond weight management GLP-1 drugs like Ozempic and Mounjaro can be covered for Type 2 diabetes, while Wegovy may be covered for cardiovascular risk reduction in qualifying patients Medicare Part B covers obesity counseling and behavioral therapy for beneficiaries with a BMI of 30 or higher when provided in primary care settings The 2025 Medicare Part D changes cap annual out-of-pocket costs at $2,000 for covered medications, significantly reducing patient expenses New pilot programs could potentially expand Medicare coverage for weight loss drugs starting as early as 2027 Medicares approach to weight loss medications creates confusion for millions of beneficiaries seeking help with weight management
Compounded tirzepatide is not the FDA-approved finished product Mounjaro or Zepbound
Our team is dedicated to providing high-quality care, with support available for both local and international patients
When combined with diet and exercise, Phentermine can help you lose weight while you establish new eating habits and engage in appropriate physical activity
BOOK YOUR CONSULTATION Depending on factors like pre-existing conditions, medical history, allergies, and medications you take, we recommend setting up a consultation to determine if semaglutide is right for you
Every 1 of those factors is within your control